Long-term outcome of deep venous thrombosis during pregnancy treated with unfractionated heparin or low molecular weight heparin

By Ulander V.-M.   Lehtola A.   Kaaja R.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 239-242

Elsevier

Access to resources Recommend Favorite

Markers of hemostatic system activation during treatment of deep vein thrombosis with subcutaneous unfractionated or low-molecular weight heparin

By Peternel P.   Terbizan M.   Tratar G.   Bozic M.   Horvat D.   Salobir B.   Stegnar M.  

Thrombosis Research, Vol. 105, Iss. 3, 2002-02 ,pp. : 241-246

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight Heparin During Pregnancy

By Bazzan M.   Donvito V.  

Thrombosis Research, Vol. 101, Iss. 1, 2001-01 ,pp. : 175-186

Elsevier

Access to resources Recommend Favorite

A descriptive evaluation of warfarin use in patients receiving hospice or palliative care services

By Hill Robin   Martinez Kerri   Delate Thomas   Witt Daniel  

Journal of Thrombosis and Thrombolysis, Vol. 27, Iss. 3, 2009-04 ,pp. : 334-339

Springer Publishing Company

Access to resources Recommend Favorite

Anti-thrombotic Efficacies of Enoxaparin, Dalteparin, and Unfractionated Heparin in Venous Thrombo-embolism

By Morris T.A.   Marsh J.J.   Konopka R.   Pedersen C.A.   Chiles P.G.  

Thrombosis Research, Vol. 100, Iss. 3, 2000-11 ,pp. : 185-194

Elsevier

Access to resources Recommend Favorite